Posts Tagged ‘ Alexion Pharmaceuticals ’

Alexion Pharmeceuticals now Connecticut’s 4th ‘First Five’ project

Jun 19th, 2012 | By

NEW HAVEN — With one dropout, the state had only approved three “First Five” projects before the announcement today of financial help for Alexion Pharmeceuticals, which will be the main tenant at Carter Winstanley’s biotech building at the heart of the ambitious reclamation of Route 34 downtown. For more on this story, visit: Alexion Pharmeceuticals

[continue reading...]